Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Variants of DENND1B associated with asthma in children.

Sleiman PM, Flory J, Imielinski M, Bradfield JP, Annaiah K, Willis-Owen SA, Wang K, Rafaels NM, Michel S, Bonnelykke K, Zhang H, Kim CE, Frackelton EC, Glessner JT, Hou C, Otieno FG, Santa E, Thomas K, Smith RM, Glaberson WR, Garris M, Chiavacci RM, Beaty TH, Ruczinski I, Orange JS, Allen J, Spergel JM, Grundmeier R, Mathias RA, Christie JD, von Mutius E, Cookson WO, Kabesch M, Moffatt MF, Grunstein MM, Barnes KC, Devoto M, Magnusson M, Li H, Grant SF, Bisgaard H, Hakonarson H.

N Engl J Med. 2010 Jan 7;362(1):36-44. doi: 10.1056/NEJMoa0901867. Epub 2009 Dec 23. Erratum in: N Engl J Med. 2010 Sep 2;363(10):994. N Engl J Med. 2012 Feb 16;366(7):672. Orange, Jordan M [corrected to Orange, Jordan S].

2.

Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene.

Himes BE, Hunninghake GM, Baurley JW, Rafaels NM, Sleiman P, Strachan DP, Wilk JB, Willis-Owen SA, Klanderman B, Lasky-Su J, Lazarus R, Murphy AJ, Soto-Quiros ME, Avila L, Beaty T, Mathias RA, Ruczinski I, Barnes KC, Celedón JC, Cookson WO, Gauderman WJ, Gilliland FD, Hakonarson H, Lange C, Moffatt MF, O'Connor GT, Raby BA, Silverman EK, Weiss ST.

Am J Hum Genet. 2009 May;84(5):581-93. doi: 10.1016/j.ajhg.2009.04.006. Epub 2009 May 7.

3.

Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function.

Ober C, Tan Z, Sun Y, Possick JD, Pan L, Nicolae R, Radford S, Parry RR, Heinzmann A, Deichmann KA, Lester LA, Gern JE, Lemanske RF Jr, Nicolae DL, Elias JA, Chupp GL.

N Engl J Med. 2008 Apr 17;358(16):1682-91. doi: 10.1056/NEJMoa0708801. Epub 2008 Apr 9.

4.

Fine mapping versus replication in whole-genome association studies.

Clarke GM, Carter KW, Palmer LJ, Morris AP, Cardon LR.

Am J Hum Genet. 2007 Nov;81(5):995-1005. Epub 2007 Sep 19.

5.

Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma.

Moffatt MF, Kabesch M, Liang L, Dixon AL, Strachan D, Heath S, Depner M, von Berg A, Bufe A, Rietschel E, Heinzmann A, Simma B, Frischer T, Willis-Owen SA, Wong KC, Illig T, Vogelberg C, Weiland SK, von Mutius E, Abecasis GR, Farrall M, Gut IG, Lathrop GM, Cookson WO.

Nature. 2007 Jul 26;448(7152):470-3. Epub 2007 Jul 4.

6.

Principal components analysis corrects for stratification in genome-wide association studies.

Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D.

Nat Genet. 2006 Aug;38(8):904-9. Epub 2006 Jul 23.

PMID:
16862161
7.

Phosphodiesterase inhibitors.

Boswell-Smith V, Spina D, Page CP.

Br J Pharmacol. 2006 Jan;147 Suppl 1:S252-7. Review.

8.

Proposal for pharmacologically distinct conformers of PDE4 cyclic AMP phosphodiesterases.

Souness JE, Rao S.

Cell Signal. 1997 May-Jun;9(3-4):227-36. Review.

PMID:
9218122
9.

Inhibition of exercise-induced asthma by an orally absorbed mast cell stabilizer (M & B 22,948).

Rudd RM, Gellert AR, Studdy PR, Geddes DM.

Br J Dis Chest. 1983 Jan;77(1):78-86.

PMID:
6344900

Supplemental Content

Support Center